Search Results - "Sosabowski, Jane K"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    High-throughput high-volume nuclear imaging for preclinical in vivo compound screening by Macholl, Sven, Finucane, Ciara M., Hesterman, Jacob, Mather, Stephen J., Pauplis, Rachel, Scully, Deirdre, Sosabowski, Jane K., Jouannot, Erwan

    Published in EJNMMI research (07-04-2017)
    “…Background Preclinical single-photon emission computed tomography (SPECT)/CT imaging studies are hampered by low throughput, hence are found typically within…”
    Get full text
    Journal Article
  6. 6

    Anesthesia and Monitoring of Animals During MRI Studies by Tremoleda, Jordi L, Macholl, Sven, Sosabowski, Jane K

    “…The use of imaging represents a major impact on the refinement and the reduction of in vivo studies in animal models, in particular for allowing longitudinal…”
    Get more information
    Journal Article
  7. 7

    Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting by Klingler, Maximilian, Decristoforo, Clemens, Rangger, Christine, Summer, Dominik, Foster, Julie, Sosabowski, Jane K, von Guggenberg, Elisabeth

    Published in Theranostics (01-01-2018)
    “…Minigastrin (MG) analogs show high affinity to the cholecystokinin-2 receptor (CCK2R) and have therefore been intensively studied to find a suitable analog for…”
    Get full text
    Journal Article
  8. 8

    Selection of radionuclide(s) for targeted alpha therapy based on their nuclear decay properties by Ree, Samantha M, Greenwood, Howard, Young, Jennifer D, Roberts, Rachel F C, Livens, Francis R, Heath, Scott L, Sosabowski, Jane K

    Published in Nuclear medicine communications (01-06-2024)
    “…Targeted alpha therapy (TAT) is a promising form of oncology treatment utilising alpha-emitting radionuclides that can specifically accumulate at disease…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy by Hodgins, Naomi O., Al-Jamal, Wafa' T., Wang, Julie T.-W., Klippstein, Rebecca, Costa, Pedro M., Sosabowski, Jane K., Marshall, John F., Maher, John, Al-Jamal, Khuloud T.

    Published in Journal of controlled release (28-06-2017)
    “…The αvβ6 integrin receptor has been shown to be overexpressed on many types of cancer cells, resulting in a more pro-invasive and aggressive phenotype, this…”
    Get full text
    Journal Article
  13. 13

    Radiolabelled peptides for oncological diagnosis by Laverman, Peter, Sosabowski, Jane K., Boerman, Otto C., Oyen, Wim J. G.

    “…Radiolabelled receptor-binding peptides targeting receptors (over)expressed on tumour cells are widely under investigation for tumour diagnosis and therapy…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo by Suffian, Izzat Fahimuddin Bin Mohamed, Wang, Julie Tzu-Wen, Hodgins, Naomi O, Martin, Rebecca Klippstein, Garcia-Maya, Mitla, Brown, Paul, Nishimura, Yuya, Heidari, Hamed, Bals, Sara, Sosabowski, Jane, Ogino, Chiaki, Kondo, Akihiko, Al-Jamal, Khuloud T

    Published in Biomaterials (01-03-2017)
    “…Abstract Hepatitis B Virus core (HBc) particles have been studied for their potential as drug delivery vehicles for cancer therapy. HBc particles are hollow…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting by Liu, Alvin Y, Kanan, Adelle D, Radon, Tomasz P, Shah, Siama, Weeks, Mark E, Foster, Julie M, Sosabowski, Jane K, Dumartin, Laurent, Crnogorac-Jurcevic, Tatjana

    Published in Oncotarget (02-07-2019)
    “…Anterior gradient 2 (AGR2), a protein disulfide isomerase, shows two subcellular localizations: intracellular (iAGR2) and extracellular (eAGR2). In healthy…”
    Get full text
    Journal Article